145 related articles for article (PubMed ID: 21860567)
21. Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia.
Mandal S; Venkatesh P; Abbas Z; Vohra R; Garg S
Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1825-9. PubMed ID: 17345090
[TBL] [Abstract][Full Text] [Related]
22. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
Charbel Issa P; Holz FG; Scholl HP
Ophthalmology; 2007 Sep; 114(9):1736-42. PubMed ID: 17822979
[TBL] [Abstract][Full Text] [Related]
23. Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia.
Wu L; Evans T; Arévalo JF; Berrocal MH; Rodríguez FJ; Hsu M; Sánchez JG
Retina; 2008 Feb; 28(2):314-9. PubMed ID: 18301037
[TBL] [Abstract][Full Text] [Related]
24. Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis.
Surguch V; Gamulescu MA; Gabel VP
Graefes Arch Clin Exp Ophthalmol; 2007 Jun; 245(6):783-8. PubMed ID: 17120013
[TBL] [Abstract][Full Text] [Related]
25. Juxtafoveal telangiectasias.
Querques G; Delle Noci N
Ophthalmology; 2008 Sep; 115(9):1636; author reply 1636. PubMed ID: 18762079
[No Abstract] [Full Text] [Related]
26. Idiopathic juxtafoveal telangiectasis in association with celiac sprue.
Lee HC; Liu M; Ho AC
Arch Ophthalmol; 2004 Mar; 122(3):411-3. PubMed ID: 15006867
[No Abstract] [Full Text] [Related]
27. Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis.
Moon SJ; Berger AS; Tolentino MJ; Misch DM
Ophthalmic Surg Lasers Imaging; 2007; 38(2):164-6. PubMed ID: 17396701
[TBL] [Abstract][Full Text] [Related]
28. Optical coherence tomography characteristics of group 2A idiopathic parafoveal telangiectasis.
Sanchez JG; Garcia RA; Wu L; Berrocal MH; Graue-Wiechers F; Rodriguez FJ; Robledo V; Lizana C; Piskulich Z; Mendoza AJ; Velez-Vazquez W; Arevalo JF
Retina; 2007; 27(9):1214-20. PubMed ID: 18046227
[TBL] [Abstract][Full Text] [Related]
29. Fibrovascular tissue in bilateral juxtafoveal telangiectasis.
Park D; Schatz H; McDonald HR; Johnson RN
Arch Ophthalmol; 1996 Sep; 114(9):1092-6. PubMed ID: 8790094
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic juxtafoveolar retinal telangiectasis and pigment epithelial hyperplasia: an optical coherence tomographic study.
Trabucchi G; Brancato R; Pierro L; Introini U; Sannace C
Arch Ophthalmol; 1999 Mar; 117(3):405-6. PubMed ID: 10088825
[No Abstract] [Full Text] [Related]
31. Idiopathic macular telangiectasia.
Yannuzzi LA; Bardal AM; Freund KB; Chen KJ; Eandi CM; Blodi B
Arch Ophthalmol; 2006 Apr; 124(4):450-60. PubMed ID: 16606869
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis.
Potter MJ; Szabo SM; Sarraf D; Michels R; Schmidt-Erfurth U
Can J Ophthalmol; 2006 Feb; 41(1):34-7. PubMed ID: 16462869
[TBL] [Abstract][Full Text] [Related]
33. Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis.
Engelbrecht NE; Aaberg TM; Sung J; Lewis ML
Arch Ophthalmol; 2002 Mar; 120(3):320-4. PubMed ID: 11879135
[TBL] [Abstract][Full Text] [Related]
34. Intravitreous ranibizumab as treatment for macular telangiectasia type 2.
Lira RP; Silva VB; Cavalcanti TM; de Souza AC; Pinto AP
Arch Ophthalmol; 2010 Aug; 128(8):1075-8. PubMed ID: 20697014
[No Abstract] [Full Text] [Related]
35. Classification of the spectrum of Coats' disease as subtypes of idiopathic retinal telangiectasis with exudation.
Cahill M; O'Keefe M; Acheson R; Mulvihill A; Wallace D; Mooney D
Acta Ophthalmol Scand; 2001 Dec; 79(6):596-602. PubMed ID: 11782226
[TBL] [Abstract][Full Text] [Related]
36. Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization.
De Lahitte GD; Cohen SY; Gaudric A
Am J Ophthalmol; 2004 Nov; 138(5):892-4. PubMed ID: 15531343
[TBL] [Abstract][Full Text] [Related]
37. Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis.
Cohen SM; Cohen ML; El-Jabali F; Pautler SE
Retina; 2007 Jan; 27(1):59-66. PubMed ID: 17218917
[TBL] [Abstract][Full Text] [Related]
38. Long-term juxtafoveal retinal telangiectasia.
Watzke RC; Klein ML; Folk JC; Farmer SG; Munsen RS; Champfer RJ; Sletten KR
Retina; 2005 Sep; 25(6):727-35. PubMed ID: 16141860
[TBL] [Abstract][Full Text] [Related]
39. Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia.
Hirano Y; Yasukawa T; Usui Y; Nozaki M; Ogura Y
Br J Ophthalmol; 2010 May; 94(5):600-5. PubMed ID: 19846412
[TBL] [Abstract][Full Text] [Related]
40. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
Kovach JL; Rosenfeld PJ
Retina; 2009 Jan; 29(1):27-32. PubMed ID: 18936721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
